{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:18:02Z","timestamp":1790162282814,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/md.0000000000000809","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T20:18:14Z","timestamp":1430511494000},"page":"e809","source":"Crossref","is-referenced-by-count":54,"title":["An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population"],"prefix":"10.1097","volume":"94","author":[{"given":"Hsin-I","family":"Shih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Chin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsien","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-45-20210309","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1192\/bjp.164.6.796","article-title":"Dementia among the elderly in a rural Korean community","volume":"164","author":"Park","year":"1994","journal-title":"Br J Psychiatry"},{"key":"R2-45-20210309","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2010.01.009","article-title":"2010 Alzheimers disease facts and figures.","volume":"6","year":"2010","journal-title":"Alzheimers Dement"},{"key":"R3-45-20210309","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"R4-45-20210309","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/YCO.0b013e32816ebc7b","article-title":"The epidemiology of the dementias: an update","volume":"20","author":"Qiu","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"R5-45-20210309","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00002093-200304000-00002","article-title":"The magnitude of dementia occurrence in the world","volume":"17","author":"Wimo","year":"2003","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R6-45-20210309","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5507\/bp.2012.055","article-title":"Epidemiological of and risk factors for Alzheimer's disease: a review","volume":"156","author":"Povova","year":"2012","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"R7-45-20210309","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1100\/tsw.2006.243","article-title":"Anterograde and retrograde effects of benzodiazepines on memory","volume":"6","author":"Beracochea","year":"2006","journal-title":"Sci World J"},{"key":"R8-45-20210309","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jech-2011-200314","article-title":"Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)","volume":"66","author":"Gallacher","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"R9-45-20210309","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"key":"R10-45-20210309","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0895-4356(01)00453-X","article-title":"Benzodiazepine use and risk of dementia: a nested case-control study","volume":"55","author":"Lagnaoui","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"R11-45-20210309","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/JGP.0b013e3181e049ca","article-title":"Effect of benzodiazepine discontinuation on dementia risk","volume":"19","author":"Wu","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"key":"R12-45-20210309","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JGP.0b013e3181a65210","article-title":"The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data","volume":"17","author":"Wu","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"R13-45-20210309","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00003495-200059040-00014","article-title":"Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia","volume":"59","author":"Holm","year":"2000","journal-title":"Drugs"},{"key":"R14-45-20210309","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MJT.0b013e31804c7292","article-title":"Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms","volume":"14","author":"Barkin","year":"2007","journal-title":"Am J Ther"},{"key":"R16-45-20210309","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0929-6646(09)60402-2","article-title":"Risk factors for dementia","volume":"108","author":"Chen","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"R17-45-20210309","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1192\/apt.7.1.24","article-title":"Risk factors for dementia","volume":"7","author":"McCullagh","year":"2001","journal-title":"Adv Psychiatr Treat"},{"key":"R18-45-20210309","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Annu Rev Neurosci"},{"key":"R19-45-20210309","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"R20-45-20210309","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.exger.2012.07.014","article-title":"An update on type 2 diabetes, vascular dementia and Alzheimer's disease","volume":"47","author":"Exalto","year":"2012","journal-title":"Exp Gerontol"},{"key":"R21-45-20210309","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.5665\/sleep.2802","article-title":"Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons","volume":"36","author":"Lim","year":"2013","journal-title":"Sleep"},{"key":"R22-45-20210309","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0033291704003897","article-title":"Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies","volume":"35","author":"Verdoux","year":"2005","journal-title":"Psychol Med"},{"key":"R23-45-20210309","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","article-title":"Drug-induced cognitive impairment in the elderly","volume":"15","author":"Moore","year":"1999","journal-title":"Drugs aging"},{"key":"R24-45-20210309","first-page":"1405","article-title":"Drug-induced cognitive impairment","volume":"64","author":"Shinohara","year":"2012","journal-title":"Brain Nerve"},{"key":"R25-45-20210309","doi-asserted-by":"crossref","first-page":"e8343","DOI":"10.1136\/bmj.e8343","article-title":"Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration","volume":"345","author":"Huedo-Medina","year":"2012","journal-title":"BMJ"},{"key":"R26-45-20210309","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1017\/S0033291703008213","article-title":"Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life","volume":"33","author":"Curran","year":"2003","journal-title":"Psychol Med"},{"key":"R27-45-20210309","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1532-5415.2001.49280.x","article-title":"Zolpidem use and hip fractures in older people","volume":"49","author":"Wang","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"R28-45-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jhm.1985","article-title":"Zolpidem is independently associated with increased risk of inpatient falls","volume":"8","author":"Kolla","year":"2013","journal-title":"J Hosp Med"},{"key":"R29-45-20210309","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3961\/jpmph.2012.45.4.219","article-title":"Zolpidem use and risk of fracture in elderly insomnia patients","volume":"45","author":"Kang","year":"2012","journal-title":"J Prev Med Public Health"},{"key":"R30-45-20210309","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0091-3057(98)00102-6","article-title":"Behavioral pharmacology of zolpidem relative to benzodiazepines: a review","volume":"61","author":"Rush","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"R31-45-20210309","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pbb.2012.12.018","article-title":"Cognition-impairing effects of benzodiazepine-type drugs: role of GABAA receptor subtypes in an executive function task in rhesus monkeys","volume":"104","author":"Makaron","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"R32-45-20210309","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet Neurol"},{"key":"R33-45-20210309","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0306-4522(96)00137-6","article-title":"Aging-related subunit expression changes of the GABAA receptor in the rat hippocampus","volume":"74","author":"Gutierrez","year":"1996","journal-title":"Neuroscience"},{"key":"R34-45-20210309","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1471-4159.1995.64020867.x","article-title":"Aging-associated changes in the pharmacological properties of the benzodiazepine (omega) receptor isotypes in the rat hippocampus","volume":"64","author":"Ruano","year":"1995","journal-title":"J Neurochem"},{"key":"R35-45-20210309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jchemneu.2004.05.003","article-title":"Subregional analysis of GABA(A) receptor subunit mRNAs in the hippocampus of older persons with and without cognitive impairment","volume":"28","author":"Rissman","year":"2004","journal-title":"J Chem Neuroanat"},{"key":"R36-45-20210309","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0006-8993(98)00437-5","article-title":"Immunohistochemical study of GABAA receptor alpha1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes","volume":"799","author":"Mizukami","year":"1998","journal-title":"Brain Res"},{"key":"R37-45-20210309","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00003088-200443040-00002","article-title":"Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone","volume":"43","author":"Drover","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R38-45-20210309","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.forsciint.2012.08.035","article-title":"CYP3A4 and CYP2C19 genetic polymorphisms and zolpidem metabolism in the Chinese Han population: a pilot study","volume":"227","author":"Shen","year":"2013","journal-title":"Forensic Sci Int"},{"key":"R39-45-20210309","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/13803395.2014.928268","article-title":"The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis","volume":"36","author":"Stranks","year":"2014","journal-title":"J Clin Exp Neuropsychol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:43:41Z","timestamp":1620960221000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201505010-00045"}},"subtitle":["A Population-Based Case-Control Study"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":38,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000809","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}